메뉴 건너뛰기




Volumn 23, Issue 12, 2010, Pages 1596-1604

Epidermal growth factor receptor in adrenocortical tumors: Analysis of gene sequence, protein expression and correlation with clinical outcome

Author keywords

adrenal cancer; adrenocortical adenoma; EGFR

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

EID: 78649705561     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.153     Document Type: Article
Times cited : (43)

References (47)
  • 1
    • 0037418546 scopus 로고    scopus 로고
    • Management of the clinically inapparent adrenal mass ('incidentaloma')
    • Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinically inapparent adrenal mass ('incidentaloma'). Ann Intern Med 2003;138:424-429.
    • (2003) Ann Intern Med , vol.138 , pp. 424-429
    • Grumbach, M.M.1    Biller, B.M.2    Braunstein, G.D.3
  • 2
    • 1942436088 scopus 로고    scopus 로고
    • The clinically inapparent adrenal mass: Update in diagnosis and management
    • Mansmann G, Lau J, Balk E, et al. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004;25:309-340.
    • (2004) Endocr Rev , vol.25 , pp. 309-340
    • Mansmann, G.1    Lau, J.2    Balk, E.3
  • 3
    • 0024513504 scopus 로고
    • Pathologic features of prognostic significance in adrenocortical carcinoma
    • Weiss LM, Medeiros LJ, Vickery Jr AL. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 1989;13:202-206.
    • (1989) Am J Surg Pathol , vol.13 , pp. 202-206
    • Weiss, L.M.1    Medeiros, L.J.2    Vickery Jr., A.L.3
  • 4
    • 0034477224 scopus 로고    scopus 로고
    • Histopathological classification of adrenal tumours
    • Saeger W. Histopathological classification of adrenal tumours. Eur J Clin Invest 2000;30(Suppl 3):58-62.
    • (2000) Eur J Clin Invest , vol.30 , Issue.SUPPL. 3 , pp. 58-62
    • Saeger, W.1
  • 5
    • 34347354300 scopus 로고    scopus 로고
    • Recent advances in histopathology and immunohistochemistry of adre-nocortical carcinoma
    • Sasano H, Suzuki T, Moriya T. Recent advances in histopathology and immunohistochemistry of adre-nocortical carcinoma. Endocr Pathol 2006;17:345-354.
    • (2006) Endocr Pathol , vol.17 , pp. 345-354
    • Sasano, H.1    Suzuki, T.2    Moriya, T.3
  • 6
    • 0034651712 scopus 로고    scopus 로고
    • Adrenocortical carcinoma: Clinical and laboratory observations
    • Wajchenberg BL, Albergaria Pereira MA, Medonca BB, et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer 2000;88:711-736.
    • (2000) Cancer , vol.88 , pp. 711-736
    • Wajchenberg, B.L.1    Pereira Ma, A.2    Medonca, B.B.3
  • 7
    • 34249810952 scopus 로고    scopus 로고
    • Adrenocortical cancer: Pathophysiology and clinical management
    • Libe R, Fratticci A, Bertherat J. Adrenocortical cancer: pathophysiology and clinical management. Endocr Relat Cancer 2007;14:13-28.
    • (2007) Endocr Relat Cancer , vol.14 , pp. 13-28
    • Libe, R.1    Fratticci, A.2    Bertherat, J.3
  • 8
    • 17644399691 scopus 로고    scopus 로고
    • Management of patients with adrenal cancer: Recommendations of an international consensus conference
    • Schteingart DE, Doherty GM, Gauger PG, et al. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 2005;12:667-680.
    • (2005) Endocr Relat Cancer , vol.12 , pp. 667-680
    • De, S.1    Doherty, G.M.2    Gauger, P.G.3
  • 9
    • 33744952176 scopus 로고    scopus 로고
    • Clinical review: Adrenocortical carcinoma: Clinical update
    • Allolio B, Fassnacht M. Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 2006;91:2027-2037.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 2027-2037
    • Allolio, B.1    Fassnacht, M.2
  • 10
    • 0036298023 scopus 로고    scopus 로고
    • Signaling pathways in adrenocortical cancer
    • Kirschner LS. Signaling pathways in adrenocortical cancer. Ann NY Acad Sci 2002;968:222-239.
    • (2002) Ann NY Acad Sci , vol.968 , pp. 222-239
    • Kirschner, L.S.1
  • 11
    • 2442532063 scopus 로고    scopus 로고
    • Adrenocortical cancer: Recent clinical and molecular advances
    • Sidhu S, Sywak M, Robinson B, et al. Adrenocortical cancer: recent clinical and molecular advances. Curr Opin Oncol 2004;16:13-18.
    • (2004) Curr Opin Oncol , vol.16 , pp. 13-18
    • Sidhu, S.1    Sywak, M.2    Robinson, B.3
  • 12
    • 27644431904 scopus 로고    scopus 로고
    • Molecular genetics of adrenocor-tical tumours, from familial to sporadic diseases
    • Libe R, Bertherat J. Molecular genetics of adrenocor-tical tumours, from familial to sporadic diseases. Eur J Endocrinol 2005;153:477-487.
    • (2005) Eur J Endocrinol , vol.153 , pp. 477-487
    • Libe, R.1    Bertherat, J.2
  • 13
    • 0020424709 scopus 로고
    • Syn thesis, turnover, and down-regulation of epidermal growth factor receptors in human A431 epidermoid carcinoma cells and skin fibroblasts
    • Krupp MN, Connolly DT, Lane MD. Synthesis, turnover, and down-regulation of epidermal growth factor receptors in human A431 epidermoid carcinoma cells and skin fibroblasts. J Biol Chem 1982;257: 11489-11496.
    • (1982) J Biol Chem , vol.257 , pp. 11489-11496
    • Krupp, M.N.1    Connolly, D.T.2    Lane, M.D.3
  • 14
    • 0022600388 scopus 로고
    • The neu oncogene encodes an epidermal growth factor receptor-related protein
    • Bargmann CI, Hung MC, Weinberg RA. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 1986;319:226-230.
    • (1986) Nature , vol.319 , pp. 226-230
    • Bargmann, C.I.1    Hung, M.C.2    Weinberg, R.A.3
  • 15
    • 31544462308 scopus 로고    scopus 로고
    • Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary disease
    • De Boer WI, Hau CM, van Schadewijk A, et al. Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary disease. Am J Clin Pathol 2006;125:184-192.
    • (2006) Am J Clin Pathol , vol.125 , pp. 184-192
    • De Boer, W.I.1    Hau, C.M.2    Van Schadewijk, A.3
  • 16
    • 0030795612 scopus 로고    scopus 로고
    • The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions
    • Alroy I, Yarden Y. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett 1997;410:83-86.
    • (1997) FEBS Lett , vol.410 , pp. 83-86
    • Alroy, I.1    Yarden, Y.2
  • 17
    • 0034773992 scopus 로고    scopus 로고
    • The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities
    • Yarden Y. The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities. Eur J Cancer 2001;37(Suppl 4):S3-S8.
    • (2001) Eur J Cancer , vol.37 , Issue.SUPPL. 4
    • Yarden, Y.1
  • 18
    • 21344432989 scopus 로고    scopus 로고
    • Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetux-imab: An Acta Oncologica expert report
    • Nygren P, Sorbye H, Osterlund P, et al. Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetux-imab: an Acta Oncologica expert report. Acta Oncol 2005;44:203-217.
    • (2005) Acta Oncol , vol.44 , pp. 203-217
    • Nygren, P.1    Sorbye, H.2    Osterlund, P.3
  • 19
    • 27144441838 scopus 로고    scopus 로고
    • The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: What's genetics got to do with it
    • Shelton JG, Steelman LS, Abrams SL, et al. The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what's genetics got to do with it- Expert Opin Ther Targets 2005;9:1009-1030.
    • (2005) Expert Opin Ther Targets , vol.9 , pp. 1009-1030
    • Shelton, J.G.1    Steelman, L.S.2    Abrams, S.L.3
  • 20
    • 9144256014 scopus 로고    scopus 로고
    • Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer
    • Selvaggi G, Novello S, Torri V, et al. Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer. Ann Oncol 2004;15:28-32.
    • (2004) Ann Oncol , vol.15 , pp. 28-32
    • Selvaggi, G.1    Novello, S.2    Torri, V.3
  • 21
    • 0036164390 scopus 로고    scopus 로고
    • Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer
    • Tsutsui S, Ohno S, Murakami S, et al. Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer. Breast Cancer Res Treat 2002;71:67-75.
    • (2002) Breast Cancer Res Treat , vol.71 , pp. 67-75
    • Tsutsui, S.1    Ohno, S.2    Murakami, S.3
  • 22
    • 3242720345 scopus 로고    scopus 로고
    • Cetuximab monotherapy and cetuximab plus irinotecan in irino-tecan-refractory metastatic colorectal cancer
    • Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irino-tecan-refractory metastatic colorectal cancer. N Engl J Med 2004;351:337-345.
    • (2004) N Engl J Med , vol.351 , pp. 337-345
    • Cunningham, D.1    Humblet, Y.2    Siena, S.3
  • 23
    • 22044445517 scopus 로고    scopus 로고
    • Erlotinib in previously treated non-small-cell lung cancer
    • Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005;353:123-132.
    • (2005) N Engl J Med , vol.353 , pp. 123-132
    • Shepherd, F.A.1    Rodrigues Pereira, J.2    Ciuleanu, T.3
  • 24
    • 34249933404 scopus 로고    scopus 로고
    • Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group
    • Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007;25:1960-1966.
    • (2007) J Clin Oncol , vol.25 , pp. 1960-1966
    • Moore, M.J.1    Goldstein, D.2    Hamm, J.3
  • 25
    • 2342471392 scopus 로고    scopus 로고
    • Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
    • Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-2139.
    • (2004) N Engl J Med , vol.350 , pp. 2129-2139
    • Lynch, T.J.1    Bell, D.W.2    Sordella, R.3
  • 26
    • 2342624080 scopus 로고    scopus 로고
    • EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy
    • Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497-1500.
    • (2004) Science , vol.304 , pp. 1497-1500
    • Paez, J.G.1    Janne, P.A.2    Lee, J.C.3
  • 27
    • 22044453790 scopus 로고    scopus 로고
    • Erlotinib in lung cancer-molecular and clinical predictors of outcome
    • Tsao MS, Sakurada A, Cutz JC, et al. Erlotinib in lung cancer-molecular and clinical predictors of outcome. N Engl J Med 2005;353:133-144.
    • (2005) N Engl J Med , vol.353 , pp. 133-144
    • Tsao, M.S.1    Sakurada, A.2    Cutz, J.C.3
  • 28
    • 32044467562 scopus 로고    scopus 로고
    • Assessing EGFR mutations
    • author reply 526-528
    • Marchetti A, Felicioni L, Buttitta F. Assessing EGFR mutations. N Engl J Med 2006;354:526-528; author reply 526-528.
    • (2006) N Engl J Med , vol.354 , pp. 526-528
    • Marchetti, A.1    Felicioni, L.2    Buttitta, F.3
  • 29
    • 29144496089 scopus 로고    scopus 로고
    • Mutations of the epidermal growth factor receptor in non-small cell lung cancer-search and destroy
    • Chan SK, Gullick WJ, Hill ME. Mutations of the epidermal growth factor receptor in non-small cell lung cancer-search and destroy. Eur J Cancer 2006;42:17-23.
    • (2006) Eur J Cancer , vol.42 , pp. 17-23
    • Chan, S.K.1    Gullick, W.J.2    Hill, M.E.3
  • 30
    • 33846444010 scopus 로고    scopus 로고
    • Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing
    • Sequist LV, Joshi VA, Janne PA, et al. Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing. Oncologist 2007;12:90-98.
    • (2007) Oncologist , vol.12 , pp. 90-98
    • Sequist, L.V.1    Joshi, V.A.2    Janne, P.A.3
  • 31
    • 0030890465 scopus 로고    scopus 로고
    • Biological characteristics of adrenocortical carcinoma: A study of p53, IGF, EGF-r, Ki-67 and PCNA in 17 adrenocortical carcinomas
    • Edgren M, Eriksson B, Wilander E, et al. Biological characteristics of adrenocortical carcinoma: a study of p53, IGF, EGF-r, Ki-67 and PCNA in 17 adrenocortical carcinomas. Anticancer Res 1997;17:1303-1309. (Pubitemid 27182456)
    • (1997) Anticancer Research , vol.17 , Issue.2 B , pp. 1303-1309
    • Edgren, M.1    Eriksson, B.2    Wilander, E.3    Westlin, J.-E.4    Nilsson, S.5    Oberg, K.6
  • 32
    • 0025193837 scopus 로고
    • Immunohisto-chemical expression of epidermal growth factor receptors in human adrenocortical carcinoma
    • Kamio T, Shigematsu K, Sou H, et al. Immunohisto-chemical expression of epidermal growth factor receptors in human adrenocortical carcinoma. Hum Pathol 1990;21:277-282.
    • (1990) Hum Pathol , vol.21 , pp. 277-282
    • Kamio, T.1    Shigematsu, K.2    Sou, H.3
  • 33
    • 0028512184 scopus 로고
    • Transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor expression in normal and diseased human adrenal cortex by immunohisto-chemistry and in situ hybridization
    • Sasano H, Suzuki T, Shizawa S, et al. Transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor expression in normal and diseased human adrenal cortex by immunohisto-chemistry and in situ hybridization. Mod Pathol 1994; 7:741-746.
    • (1994) Mod Pathol , vol.7 , pp. 741-746
    • Sasano, H.1    Suzuki, T.2    Shizawa, S.3
  • 34
    • 66349120812 scopus 로고    scopus 로고
    • An analysis of potential surrogate markers of target-specific therapy in archival materials of adrenocortical carcinoma
    • Nakamura M, Miki Y, Akahira J, et al. An analysis of potential surrogate markers of target-specific therapy in archival materials of adrenocortical carcinoma. Endocr Pathol 2009;20:17-23.
    • (2009) Endocr Pathol , vol.20 , pp. 17-23
    • Nakamura, M.1    Miki, Y.2    Akahira, J.3
  • 35
    • 71149093992 scopus 로고    scopus 로고
    • Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma
    • Fenske W, Volker HU, Adam P, et al. Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma. Endocr Relat Cancer 2009;16:919-928.
    • (2009) Endocr Relat Cancer , vol.16 , pp. 919-928
    • Fenske, W.1    Volker, H.U.2    Adam, P.3
  • 36
    • 72749100910 scopus 로고    scopus 로고
    • Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy
    • Ronchi CL, Sbiera S, Kraus L, et al. Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy. Endocr Relat Cancer 2009;16:907-918.
    • (2009) Endocr Relat Cancer , vol.16 , pp. 907-918
    • Ronchi, C.L.1    Sbiera, S.2    Kraus, L.3
  • 37
    • 66849087625 scopus 로고    scopus 로고
    • Osteopontin stimulates invasion of NCI-h295 cells but is not associated with survival in adrenocortical carcinoma
    • Weismann D, Briese J, Niemann J, et al. Osteopontin stimulates invasion of NCI-h295 cells but is not associated with survival in adrenocortical carcinoma. J Pathol 2009;218:232-240.
    • (2009) J Pathol , vol.218 , pp. 232-240
    • Weismann, D.1    Briese, J.2    Niemann, J.3
  • 38
    • 0029844506 scopus 로고    scopus 로고
    • The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer
    • Ioachim E, Kamina S, Athanassiadou S, et al. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer. Anticancer Res 1996;16:3141-3147.
    • (1996) Anticancer Res , vol.16 , pp. 3141-3147
    • Ioachim, E.1    Kamina, S.2    Athanassiadou, S.3
  • 39
    • 33751247325 scopus 로고    scopus 로고
    • Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: Diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas
    • Volante M, Sperone P, Bollito E, et al. Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas. Mod Pathol 2006;19:1563-1569.
    • (2006) Mod Pathol , vol.19 , pp. 1563-1569
    • Volante, M.1    Sperone, P.2    Bollito, E.3
  • 40
    • 0034839753 scopus 로고    scopus 로고
    • Discerning malignancy in adrenocortical tumors: Are molecular markers useful
    • Wachenfeld C, Beuschlein F, Zwermann O, et al. Discerning malignancy in adrenocortical tumors: are molecular markers useful- Eur J Endocrinol 2001;145:335-341.
    • (2001) Eur J Endocrinol , vol.145 , pp. 335-341
    • Wachenfeld, C.1    Beuschlein, F.2    Zwermann, O.3
  • 41
    • 42649093507 scopus 로고    scopus 로고
    • The role of immunohistochemistry in histopathological diagnostics of clinically 'silent' incidentally detected adrenal masses
    • Babinska A, Sworczak K, Wisniewski P, et al. The role of immunohistochemistry in histopathological diagnostics of clinically 'silent' incidentally detected adrenal masses. Exp Clin Endocrinol Diabetes 2008;116:246-251.
    • (2008) Exp Clin Endocrinol Diabetes , vol.116 , pp. 246-251
    • Babinska, A.1    Sworczak, K.2    Wisniewski, P.3
  • 42
    • 33747404192 scopus 로고    scopus 로고
    • IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours
    • Schmitt A, Saremaslani P, Schmid S, et al. IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours. Histopathology 2006;49:298-307.
    • (2006) Histopathology , vol.49 , pp. 298-307
    • Schmitt, A.1    Saremaslani, P.2    Schmid, S.3
  • 43
    • 0029838924 scopus 로고    scopus 로고
    • MHC class II expression-a new tool to assess dignity in adreno-cortical tumours
    • Marx C, Wolkersdorfer GW, Brown JW, et al. MHC class II expression-a new tool to assess dignity in adreno-cortical tumours. J Clin Endocrinol Metab 1996;81: 4488-4491.
    • (1996) J Clin Endocrinol Metab , vol.81 , pp. 4488-4491
    • Marx, C.1    Wolkersdorfer, G.W.2    Brown, J.W.3
  • 44
    • 0034947649 scopus 로고    scopus 로고
    • EGF mutant receptor vIII as a molecular target in cancer therapy
    • Kuan CT, Wikstrand CJ, Bigner DD. EGF mutant receptor vIII as a molecular target in cancer therapy. Endocr Relat Cancer 2001;8:83-96.
    • (2001) Endocr Relat Cancer , vol.8 , pp. 83-96
    • Kuan, C.T.1    Wikstrand, C.J.2    Bigner, D.D.3
  • 45
    • 45149110737 scopus 로고    scopus 로고
    • Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine
    • Quinkler M, Hahner S, Wortmann S, et al. Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine. J Clin Endocrinol Metab 2008;93: 2057-2062.
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 2057-2062
    • Quinkler, M.1    Hahner, S.2    Wortmann, S.3
  • 46
    • 65749120532 scopus 로고    scopus 로고
    • New targets and therapeutic approaches for endocrine malignancies
    • Fassnacht M, Kreissl MC, Weismann D, et al. New targets and therapeutic approaches for endocrine malignancies. Pharmacol Ther 2009;123: 117-141.
    • (2009) Pharmacol Ther , vol.123 , pp. 117-141
    • Fassnacht, M.1    Kreissl, M.C.2    Weismann, D.3
  • 47
    • 59449084843 scopus 로고    scopus 로고
    • Limited prognostic value of the 2004 UICC staging classification for adrenocortical carcinoma-proposal for a revised TNM classification
    • Fassnacht M, Johanssen S, Quinkler M, et al. Limited prognostic value of the 2004 UICC staging classification for adrenocortical carcinoma-proposal for a revised TNM classification. Cancer 2009; 115:243-250.
    • (2009) Cancer , vol.115 , pp. 243-250
    • Fassnacht, M.1    Johanssen, S.2    Quinkler, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.